Human Disease | Mouse Models | ||||
---|---|---|---|---|---|
|
IDs
|
View 3 models | |||
|
IDs
|
View 1 model | |||
|
IDs
|
||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
early conceptus |
embryo ectoderm |
embryo endoderm |
embryo mesoderm |
embryo mesenchyme |
extraembryonic component |
alimentary system |
auditory system |
branchial arches |
cardiovascular system |
connective tissue |
endocrine system |
exocrine system |
hemolymphoid system |
integumental system |
limbs |
liver and biliary system |
musculoskeletal system |
nervous system |
olfactory system |
reproductive system |
respiratory system |
urinary system |
visual system |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transcription Start Site | Location | Distance from Gene 5'-end |
Tssr105225 | Chr11:102320179-102320199 (+) | -1,144 bp |
Tssr105226 | Chr11:102321194-102321225 (+) | -123 bp |
Tssr105227 | Chr11:102321289-102321349 (+) | -14 bp |
Tssr105228 | Chr11:102323381-102323407 (+) | 2,061 bp |
Tssr105229 | Chr11:102323612-102323628 (+) | 2,287 bp |
Tssr105230 | Chr11:102323648-102323671 (+) | 2,327 bp |
Tssr105231 | Chr11:102323676-102323690 (+) | 2,350 bp |
Tssr105232 | Chr11:102323712-102323736 (+) | 2,391 bp |
Tssr105233 | Chr11:102323826-102323853 (+) | 2,507 bp |
Tssr105234 | Chr11:102323856-102323877 (+) | 2,534 bp |
Tssr105235 | Chr11:102323895-102323908 (+) | 2,569 bp |
Tssr105236 | Chr11:102324042-102324063 (+) | 2,720 bp |
Tssr105237 | Chr11:102324065-102324141 (+) | 2,770 bp |
Tssr105238 | Chr11:102324144-102324155 (+) | 2,817 bp |
Tssr105239 | Chr11:102324299-102324340 (+) | 2,987 bp |
Tssr105240 | Chr11:102324344-102324360 (+) | 3,019 bp |
Tssr105241 | Chr11:102324750-102324783 (+) | 3,434 bp |
Tssr105242 | Chr11:102324786-102324817 (+) | 3,469 bp |
Tssr105243 | Chr11:102324952-102324960 (+) | 3,623 bp |
Tssr105244 | Chr11:102324967-102324980 (+) | 3,641 bp |
Tssr105245 | Chr11:102324986-102324997 (+) | 3,659 bp |
Tssr105246 | Chr11:102325005-102325016 (+) | 3,678 bp |
Tssr105247 | Chr11:102325033-102325064 (+) | 3,716 bp |
Tssr105248 | Chr11:102325217-102325264 (+) | 3,908 bp |
Tssr105249 | Chr11:102325270-102325297 (+) | 3,951 bp |
Tssr105250 | Chr11:102325304-102325315 (+) | 3,977 bp |
Tssr105251 | Chr11:102325526-102325628 (+) | 4,244 bp |
Tssr105252 | Chr11:102325887-102325901 (+) | 4,561 bp |
Tssr105253 | Chr11:102325904-102325939 (+) | 4,589 bp |
Tssr105254 | Chr11:102326064-102326083 (+) | 4,741 bp |
Tssr105255 | Chr11:102326084-102326093 (+) | 4,756 bp |
Tssr105256 | Chr11:102326104-102326123 (+) | 4,781 bp |
Tssr105257 | Chr11:102326141-102326155 (+) | 4,815 bp |
Tssr105258 | Chr11:102326171-102326196 (+) | 4,851 bp |
Tssr105259 | Chr11:102326530-102326553 (+) | 5,209 bp |
Tssr105260 | Chr11:102326567-102326582 (+) | 5,242 bp |
Tssr105261 | Chr11:102326621-102326690 (+) | 5,323 bp |
Tssr105262 | Chr11:102326706-102326721 (+) | 5,381 bp |
Tssr105263 | Chr11:102326866-102326878 (+) | 5,539 bp |
Tssr105264 | Chr11:102326925-102326976 (+) | 5,618 bp |
Tssr105265 | Chr11:102326990-102327015 (+) | 5,670 bp |
Tssr105266 | Chr11:102327195-102327206 (+) | 5,868 bp |
Tssr105267 | Chr11:102327301-102327310 (+) | 5,973 bp |
Tssr105268 | Chr11:102327346-102327360 (+) | 6,020 bp |
QTL | Genetic Location* | Genome Location (GRCm39) | Reference | QTL Note |
Par8 | Chr11, syntenic | Chr11:94063779-94063918 | J:78525 | Microarray gene expression analysis was used to identify candidate genes for tumor resistant and tumor susceptibility QTLs Par8,2,3,4 and and Pas1-4, respectively. Transcripts found within the flanking markers of each QTL were identified and matched to transcripts from Affymetrix probe sets. RNA from A/J, BALB/cJ, C57BL/6J, and SM/J were used for analysis. Pas1 is located between 48.2 cM and 75 cM on mouse Chromosome 6 and was identified in a cross between A/J and C57BL/6J. Candidate oncogenic genes identified by microarray analysis are hes related protein (**Note- this gene is not found in MGD), Ppih (cyclophilin H **Note-this gene is positioned on mouse Chromosome 4 in MGD), Ptpro, Mglap, Recql, and Bcat1 (ECA39). Other candidate genes identified via differential expression are Ccnd2 (cyclin D2) and high mobility group protein 2A,4 (**Note-this gene is not found in MGD). K-ras, a positional candidate gene, did not show significantly different expression between A/J and C57BL/6J. Pas2 is located between 17 cMand 23.2 cM on mouse Chromosome 17 and was identified in crosses involving A/J and C57BL/6J. Candidate oncogenic genes identified by microarray analysis are Notch4, Hnrpk (**Note-this gene is positioned on mouse Chromosome 13 in MGD), and Enpp4. Other candidate genes identified via differential expression are Cdc5l, Tapbp (tapasin), H2-Ke2, Rbx1 (regulator of cullins 1 **Note- this gene is found on mouse Chromosome 15 in MGD), Psors1c2, H2-Ke6, and H2-M9. Positional candidate genes Tnf (Tnfa) and Lta (Tnfb) did not show significantly different expression between A/J and C57BL/6J. Pas3 is located between 2 cM and 25 cM on mouse Chromosome 19 and was identified in a cross between A/J and C57BL/6J. Candidate oncogenic genes identified by microarray analysis are golgi specific Gbf1 (brefeldin A resistance factor 1) and Sema4g. Other candidate genes identified via differential expression are Pdcd4, Adrb1, and Cdc25l. Pas4 is located between 42 cM and 72 cM on mouse Chromosome 9 and was identified in a cross between A/J and C57BL/6J. Candidate oncogenic genes identified by microarray analysis are Nck1, Pthr1, and Topbp1. Candidate tumor suppressor genes for Pas4 are G protein alpha I 2 (**Note-this gene is not found in MGD), Cdk5 (**Note-this gene is positioned on mouse Chromosome 5 in MGD), Smarcd3 (**Note-this gene is positioned on mouse Chromosome 5 in MGD), and Nckipsd. Another candidate gene identified via differential expression is Stag1. Par1 is located between 37 cM and 59 cM on mouse Chromosome 11 and was identified in a cross between A/J and SM/J. Candidate oncogenic genes identified by microarray analysis are Alox12 (12-lipoxygenase), Zfp617 (zinc finger protein s11-6), Grn, and Rpl29 (**Note-this gene is positioned on mouse Chromosome 9 in MGD). A tumor suppressor candidate gene for Par1 is Spop. 02.05.2016 Curator Note: Because Par1 was originally mapped in J:32079 using an (A/J x M. spretus) x C57BL/6J interspecific backcross, which differs from the cross used here, we have equated this QTL with Par8 which was mapped using A/J and SM/J mice, see J:41849. Par2 is located between 32 cM and 57 cM on mouse Chromosome 18 and was identified in a cross between A/J and BALB/cJ. Candidate oncogenic genes identified by microarray analysis are Adrb2, Mbd2, Htr4, Hmgb1-rs12, and Iigp1. Dcc is an expected candidate gene of Par2 but its expression pattern (A/J=high expression) is not consistent with its effect on tumor resistance/susceptibility. Mc2r is another candidate gene identified via differential gene expression between A/J and SM/J. Par3 is located between 13 cM and 44 cM on mouse Chromosome 12 and was identified in a cross between A/J and SM/J. Only one candidate oncogenic gene was identified for Par3. This is placental growth factor, Pgf. Par4 is located between 10.6 cM and 42.5 cM on mouse Chromosome 4 and was identified in a cross between A/J and BALB/cJ. Candidate tumor suppressor genes identified via differential gene expression are Cdkn2a, Egfl5, Ambp (bikunin), Pole3, Tyrp1, Ifnab, and Igfbpl1.Candidate oncogenes are T complex protein 1 alpha (**Note-this gene is not found in MGD) and Stmn1. Another candidate gene identified via differential expression between A/J and SM/J is Ptprd. |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|